Literature DB >> 17484030

Influence of the presence of HCV-RNA in peripheral blood mononuclear cells on the clinical course of chronic hepatitis C in children.

Arleta Kowala-Piaskowska1, Iwona Mozer-Lisewska, Magdalena Figlerowicz, Wojciech Słuzewski.   

Abstract

The clinical course of chronic hepatitis C (CHC) is generally asymptomatic in children. The aim of this study was to examine the influence of HCV RNA in peripheral blood mononuclear cells (PBMCs) on the clinical course of CHC considering age at the time of infection, length of infection, hepatitis virus C (HCV) genotype, baseline viral load, ALT activity, the degree of liver fibrosis and oncologic history. The study group included forty children, aged 6-18 years with diagnosed CHC. Children were divided into two subgroups: group A (n = 28), with HCV-RNA found in PBMCs and group B (n = 12), with negative results of HCV-RNA in PBMCs. Chosen parameters were analyzed in both study groups according to the aim of the study. Similar age at the time of infection and the length of infection was found in both groups. The majority of the children were infected with genotype 1. Viral load, the stage of fibrosis and ALT activity were comparable in both groups. History of pediatric malignancy concerned the vast majority of children. Presence of HCV-RNA does not seem to influence the clinical course of HCV infection in children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484030     DOI: 10.1007/s10654-007-9125-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   12.434


  28 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Long-term outcome of hepatitis C in children.

Authors:  Flavia Bortolotti; Maria Guido; Lucia Zancan; Nadia Gussetti
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

3.  [Late spontaneous elimination of HCV-RNA from mononuclear cells derived from peripheral blood in patients with chronic hepatitis C].

Authors:  Ewa Majda-Stanisławska; Małgorzata Sidorkiewicz; Barbara Jóźwiak; Anna Pietrzak; Ewa Brzezińska-Błaszczyk
Journal:  Przegl Epidemiol       Date:  2006

4.  Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Marek Radkowski; Juan F Gallegos-Orozco; Joanna Jablonska; Thomas V Colby; Bozena Walewska-Zielecka; Joanna Kubicka; Jeffrey Wilkinson; Debra Adair; Jorge Rakela; Tomasz Laskus
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

Review 5.  Sexual and perinatal transmission of hepatitis C.

Authors:  J L Dienstag
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection.

Authors:  C Azzari; M Resti; M Moriondo; R Ferrari; P Lionetti; A Vierucci
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

7.  Hepatitis C in children.

Authors:  P A Tovo; M L Newell
Journal:  Curr Opin Infect Dis       Date:  1999-06       Impact factor: 4.915

8.  Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets.

Authors:  A M Roque Afonso; J Jiang; F Penin; C Tareau; D Samuel; M A Petit; H Bismuth; E Dussaix; C Féray
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Histopathology of the liver in children with chronic hepatitis C viral infection.

Authors:  K Badizadegan; M M Jonas; M J Ott; S P Nelson; A R Perez-Atayde
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

10.  Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.

Authors:  S D Ryder; W L Irving; D A Jones; K R Neal; J C Underwood
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

View more
  3 in total

1.  A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI).

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia T Javed; Sana Gull; Humaira Kausar; Muhammad T Sarwar; Sultan Asad; Imran Shahid; Aleena Sumrin; Saba Khaliq; Shah Jahan; Asim Pervaiz; Sajida Hassan
Journal:  BMC Gastroenterol       Date:  2011-04-21       Impact factor: 3.067

2.  Association of laboratory parameters with viral factors in patients with hepatitis C.

Authors:  Bushra Ijaz; Waqar Ahmad; Fouzia T Javed; Sana Gull; Muhammad T Sarwar; Humera Kausar; Sultan Asad; Shah Jahan; Saba Khaliq; Imran Shahid; Aleena Sumrin; Sajida Hassan
Journal:  Virol J       Date:  2011-07-21       Impact factor: 4.099

3.  HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a.

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia T Javed; Humera Kausar; Muhammad T Sarwar; Sana Gull; Sultan Asad; Imran Shahid; Sajida Hassan
Journal:  Virol J       Date:  2011-06-10       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.